FDA Approved: PEMETREXED — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for pemetrexed submitted by BluePoint Laboratories. This action approves the generic pemetrexed for distribution und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma
• Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

SUPPL AP for PEMETREXED (PEMETREXED)